Market Tracker

05/25 5:16pm ET

Incyte Corp (NASDAQ:INCY)

83.16
Delayed Data
As of 4:00pm ET
 +1.89 / +2.33%
Today’s Change
55.00
Today|||52-Week Range
133.62
-23.32%
Year-to-Date

Today’s Trading

Previous close81.27
Today’s open81.31
Day’s range80.64 - 83.50
Volume1,314,747
Average volume (3 months)2,019,161
Market cap$15.2B
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+173.33%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio327.0
Price/Sales26.95
Price/Book88.63

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.86+0.98%
PRGOPerrigo Company PLC+0.31+0.32%
MDVNMedivation Inc-0.43-0.69%
JAZZJazz Pharmaceuticals...+1.08+0.71%
Data as of 4:02pm ET, 05/25/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts